Stay updated on PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.

Latest updates to the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe page history shows a new site revision v3.5.4 replacing v3.5.3, indicating a deployment of the latest interface update. It does not modify the study information or core page content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry v3.5.3 has been added to the history, replacing the previous v3.5.2 entry. This change reflects an update to the page's revision metadata rather than changes to the study content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.5.2 to the history log and removed Revision: v3.5.0. This updates the record's version history.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3 from the history.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.3 was added to the record history, replacing the previous revision (v3.4.2).SummaryDifference0.1%

- Check85 days agoChange DetectedAdded Document Section, Contacts/Locations, and Study Identification entries (including a 'No Results Posted' status on 2026-02-19) and removed the 2024-05-31 'Results Submitted' events.SummaryDifference1%

Stay in the know with updates to PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.